James S. Good

Closest collaborators

The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Somnath Mukherjee · 4 shared papers, 2020–2024 · strength 0.55
   • Paper Stereotactic Magnetic Resonance-Guided Daily Adaptive SABR (SMART) for Localised Non-Metastatic Pancreatic Cancer: Firs… DOI 10.1016/j.clon.2024.05.012↗
   • Paper Evaluation of hypofractionated adaptive radiotherapy using the MR Linac in localised pancreatic cancer: protocol summar… DOI 10.1136/bmjopen-2022-068906↗
   • Paper Reply to Comment on "The UK consensus position on the treatment of pancreatic cancer during the COVID-19 pandemic". DOI 10.1038/s41416-020-01133-8↗
2. Nikolaos A. Chatzizacharias · 2 shared papers, 2026 · strength 0.41
   • Paper Intranetwork variation in neoadjuvant therapy delivery for borderline resectable and locally advanced pancreatic cancer… DOI 10.1308/rcsann.2026.0023↗
   • Paper Intention to treat outcomes following management of locally advanced pancreatic ductal adenocarcinoma with curative int… DOI 10.1016/j.hpb.2026.06.008↗
3. Lewis A Hall · 2 shared papers, 2026 · strength 0.41
   • Paper Intranetwork variation in neoadjuvant therapy delivery for borderline resectable and locally advanced pancreatic cancer… DOI 10.1308/rcsann.2026.0023↗
   • Paper Intention to treat outcomes following management of locally advanced pancreatic ductal adenocarcinoma with curative int… DOI 10.1016/j.hpb.2026.06.008↗
4. Peter Lawrence Zaki Labib · 2 shared papers, 2026 · strength 0.41
   • Paper Intranetwork variation in neoadjuvant therapy delivery for borderline resectable and locally advanced pancreatic cancer… DOI 10.1308/rcsann.2026.0023↗
   • Paper Intention to treat outcomes following management of locally advanced pancreatic ductal adenocarcinoma with curative int… DOI 10.1016/j.hpb.2026.06.008↗
5. Sarah F. Powell-Brett · 2 shared papers, 2026 · strength 0.41
   • Paper Intranetwork variation in neoadjuvant therapy delivery for borderline resectable and locally advanced pancreatic cancer… DOI 10.1308/rcsann.2026.0023↗
   • Paper Intention to treat outcomes following management of locally advanced pancreatic ductal adenocarcinoma with curative int… DOI 10.1016/j.hpb.2026.06.008↗
6. Moath Alarabiyat · 2 shared papers, 2026 · strength 0.41
   • Paper Intranetwork variation in neoadjuvant therapy delivery for borderline resectable and locally advanced pancreatic cancer… DOI 10.1308/rcsann.2026.0023↗
   • Paper Intention to treat outcomes following management of locally advanced pancreatic ductal adenocarcinoma with curative int… DOI 10.1016/j.hpb.2026.06.008↗
7. Shivan Sivakumar · 2 shared papers, 2026 · strength 0.41
   • Paper Intranetwork variation in neoadjuvant therapy delivery for borderline resectable and locally advanced pancreatic cancer… DOI 10.1308/rcsann.2026.0023↗
   • Paper Intention to treat outcomes following management of locally advanced pancreatic ductal adenocarcinoma with curative int… DOI 10.1016/j.hpb.2026.06.008↗
8. Killian Nugent · 2 shared papers, 2023–2024 · strength 0.36
   • Paper Stereotactic Magnetic Resonance-Guided Daily Adaptive SABR (SMART) for Localised Non-Metastatic Pancreatic Cancer: Firs… DOI 10.1016/j.clon.2024.05.012↗
   • Paper Evaluation of hypofractionated adaptive radiotherapy using the MR Linac in localised pancreatic cancer: protocol summar… DOI 10.1136/bmjopen-2022-068906↗
9. Tim Maughan · 2 shared papers, 2023–2024 · strength 0.36
   • Paper Stereotactic Magnetic Resonance-Guided Daily Adaptive SABR (SMART) for Localised Non-Metastatic Pancreatic Cancer: Firs… DOI 10.1016/j.clon.2024.05.012↗
   • Paper Evaluation of hypofractionated adaptive radiotherapy using the MR Linac in localised pancreatic cancer: protocol summar… DOI 10.1136/bmjopen-2022-068906↗
10. S. Teoh · 2 shared papers, 2023–2024 · strength 0.36
    • Paper Stereotactic Magnetic Resonance-Guided Daily Adaptive SABR (SMART) for Localised Non-Metastatic Pancreatic Cancer: Firs… DOI 10.1016/j.clon.2024.05.012↗
    • Paper Evaluation of hypofractionated adaptive radiotherapy using the MR Linac in localised pancreatic cancer: protocol summar… DOI 10.1136/bmjopen-2022-068906↗
11. Keith John Roberts · 1 shared paper, 2026 · strength 0.24
    • Paper Intranetwork variation in neoadjuvant therapy delivery for borderline resectable and locally advanced pancreatic cancer… DOI 10.1308/rcsann.2026.0023↗
12. Paula Ghaneh · 2 shared papers, 2020–2021 · strength 0.19
    • Paper Reply to Comment on "The UK consensus position on the treatment of pancreatic cancer during the COVID-19 pandemic". DOI 10.1038/s41416-020-01133-8↗
    • Paper Considerations for the treatment of pancreatic cancer during the COVID-19 pandemic: the UK consensus position. DOI 10.1038/s41416-020-0980-x↗
13. Derek B. Grose · 2 shared papers, 2020–2021 · strength 0.19
    • Paper Reply to Comment on "The UK consensus position on the treatment of pancreatic cancer during the COVID-19 pandemic". DOI 10.1038/s41416-020-01133-8↗
    • Paper Considerations for the treatment of pancreatic cancer during the COVID-19 pandemic: the UK consensus position. DOI 10.1038/s41416-020-0980-x↗
14. Katharine L. Aitken · 2 shared papers, 2020–2021 · strength 0.19
    • Paper Reply to Comment on "The UK consensus position on the treatment of pancreatic cancer during the COVID-19 pandemic". DOI 10.1038/s41416-020-01133-8↗
    • Paper Considerations for the treatment of pancreatic cancer during the COVID-19 pandemic: the UK consensus position. DOI 10.1038/s41416-020-0980-x↗
15. Christopher Mark Jones · 2 shared papers, 2020–2021 · strength 0.19
    • Paper Reply to Comment on "The UK consensus position on the treatment of pancreatic cancer during the COVID-19 pandemic". DOI 10.1038/s41416-020-01133-8↗
    • Paper Considerations for the treatment of pancreatic cancer during the COVID-19 pandemic: the UK consensus position. DOI 10.1038/s41416-020-0980-x↗
16. Daniel H. Palmer · 2 shared papers, 2020–2021 · strength 0.19
    • Paper Reply to Comment on "The UK consensus position on the treatment of pancreatic cancer during the COVID-19 pandemic". DOI 10.1038/s41416-020-01133-8↗
    • Paper Considerations for the treatment of pancreatic cancer during the COVID-19 pandemic: the UK consensus position. DOI 10.1038/s41416-020-0980-x↗
17. D. Holyoake · 2 shared papers, 2020–2021 · strength 0.19
    • Paper Reply to Comment on "The UK consensus position on the treatment of pancreatic cancer during the COVID-19 pandemic". DOI 10.1038/s41416-020-01133-8↗
    • Paper Considerations for the treatment of pancreatic cancer during the COVID-19 pandemic: the UK consensus position. DOI 10.1038/s41416-020-0980-x↗
18. Ganesh Radhakrishna · 2 shared papers, 2020–2021 · strength 0.19
    • Paper Reply to Comment on "The UK consensus position on the treatment of pancreatic cancer during the COVID-19 pandemic". DOI 10.1038/s41416-020-01133-8↗
    • Paper Considerations for the treatment of pancreatic cancer during the COVID-19 pandemic: the UK consensus position. DOI 10.1038/s41416-020-0980-x↗
19. M. Hawkins · 2 shared papers, 2020–2021 · strength 0.19
    • Paper Reply to Comment on "The UK consensus position on the treatment of pancreatic cancer during the COVID-19 pandemic". DOI 10.1038/s41416-020-01133-8↗
    • Paper Considerations for the treatment of pancreatic cancer during the COVID-19 pandemic: the UK consensus position. DOI 10.1038/s41416-020-0980-x↗
20. Nigel Balfour Jamieson · 2 shared papers, 2020–2021 · strength 0.19
    • Paper Reply to Comment on "The UK consensus position on the treatment of pancreatic cancer during the COVID-19 pandemic". DOI 10.1038/s41416-020-01133-8↗
    • Paper Considerations for the treatment of pancreatic cancer during the COVID-19 pandemic: the UK consensus position. DOI 10.1038/s41416-020-0980-x↗
21. Juan W. Valle · 2 shared papers, 2020–2021 · strength 0.19
    • Paper Reply to Comment on "The UK consensus position on the treatment of pancreatic cancer during the COVID-19 pandemic". DOI 10.1038/s41416-020-01133-8↗
    • Paper Considerations for the treatment of pancreatic cancer during the COVID-19 pandemic: the UK consensus position. DOI 10.1038/s41416-020-0980-x↗
22. Pippa G. Corrie · 2 shared papers, 2020–2021 · strength 0.19
    • Paper Reply to Comment on "The UK consensus position on the treatment of pancreatic cancer during the COVID-19 pandemic". DOI 10.1038/s41416-020-01133-8↗
    • Paper Considerations for the treatment of pancreatic cancer during the COVID-19 pandemic: the UK consensus position. DOI 10.1038/s41416-020-0980-x↗
23. David Christopher Bartlett · 1 shared paper, 2026 · strength 0.18
    • Paper Intention to treat outcomes following management of locally advanced pancreatic ductal adenocarcinoma with curative int… DOI 10.1016/j.hpb.2026.06.008↗
24. Robert Peter Sutcliffe · 1 shared paper, 2026 · strength 0.18
    • Paper Intention to treat outcomes following management of locally advanced pancreatic ductal adenocarcinoma with curative int… DOI 10.1016/j.hpb.2026.06.008↗
25. S.S. Raza · 1 shared paper, 2026 · strength 0.18
    • Paper Intention to treat outcomes following management of locally advanced pancreatic ductal adenocarcinoma with curative int… DOI 10.1016/j.hpb.2026.06.008↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.